CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. TOP INVESTMENT POCKETS
3.3. MARKET SHARE ANALYSIS
3.4. MARKET DYNAMICS

3.4.1. Drivers

3.4.1.1. Technological advancements in transcriptomics
3.4.1.2. Increase in applications of transcriptomics
3.4.1.3. Increase in research grants
3.4.1.4. Increase in genome mapping programs

3.4.2. Restraints

3.4.2.1. Standardization concerns over RNA sequencing
3.4.2.2. Lack of skilled professionals

3.4.3. Opportunity

3.4.3.1. Lucrative opportunities in emerging markets

3.4.4. Impact analysis

3.5. CLINICAL TRIALS

CHAPTER 4 TRANSCRIPTOMICS MARKET, BY TECHNOLOGY

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. MICROARRAY

4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country

4.3. REAL-TIME QUANTITATIVE POLYMERASE CHAIN REACTION(Q-PCR)

4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country

4.4. SEQUENCING TECHNOLOGIES

4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country
4.4.4. Market size and forecast, by type

4.4.4.1. Sanger sequencing

4.4.4.1.1. Market size and forecast

4.4.4.2. RNA sequencing

4.4.4.2.1. Market size and forecast

CHAPTER 5 TRANSCRIPTOMICS MARKET, BY PRODUCTS & SERVICES

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. CONSUMABLES

5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country

5.3. INSTRUMENTS

5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country

5.4. SOFTWARE

5.4.1. Market size and forecast, by region
5.4.2. Market analysis, by country

5.5. SERVICES

5.5.1. Market size and forecast, by region
5.5.2. Market analysis, by country

CHAPTER 6 TRANSCRIPTOMICS MARKET, BY APPLICATION

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. DIAGNOSTICS AND DISEASE PROFILING

6.2.1. Market size and forecast, by region
6.2.2. Market analysis, by country

6.3. DRUG DISCOVERY

6.3.1. Market size and forecast, by region
6.3.2. Market analysis, by country

6.4. OTHERS

6.4.1. Market size and forecast, by region
6.4.2. Market analysis, by country

CHAPTER 7 TRANSCRIPTOMICS MARKET, BY END USER

7.1. OVERVIEW

7.1.1. Market size and forecast

7.2. GOVERNMENT INSTITUTES AND ACADEMIC CENTERS

7.2.1. Market size and forecast, by region
7.2.2. Market analysis, by country

7.3. PHARMACEUTICAL AND BIOTECHNOLOGICAL COMPANIES

7.3.1. Market size and forecast, by region
7.3.2. Market analysis, by country

7.4. CONTRACT RESEARCH ORGANIZATION

7.4.1. Market size and forecast, by region
7.4.2. Market analysis, by country

CHAPTER 8 TRANSCRIPTOMICS MARKET, BY REGION

8.1. OVERVIEW

8.1.1. Market size and forecast

8.2. NORTH AMERICA

8.2.1. Key market trends, growth factors and opportunities
8.2.2. North America market size and forecast, by country

8.2.2.1. U.S. transcriptomics market

8.2.2.1.1. U.S. market size and forecast, by technology
8.2.2.1.2. U.S. market size and forecast, by products & services
8.2.2.1.3. U.S. market size and forecast, by application
8.2.2.1.4. U.S. market size and forecast, by end user

8.2.2.2. Canada transcriptomics market

8.2.2.2.1. Canada market size and forecast, by technology
8.2.2.2.2. Canada market size and forecast, by products & services
8.2.2.2.3. Canada market size and forecast, by application
8.2.2.2.4. Canada market size and forecast, by end user

8.2.2.3. Mexico transcriptomics market

8.2.2.3.1. Mexico market size and forecast, by technology
8.2.2.3.2. Mexico market size and forecast, by products & services
8.2.2.3.3. Mexico market size and forecast, by application
8.2.2.3.4. Mexico market size and forecast, by end user

8.2.3. North America market size and forecast, by technology
8.2.4. North America market size and forecast, by products & services
8.2.5. North America market size and forecast, by application
8.2.6. North America market size and forecast, by end user

8.3. EUROPE

8.3.1. Key market trends, growth factors and opportunities
8.3.2. Europe market size and forecast, by country

8.3.2.1. Germany transcriptomics market

8.3.2.1.1. Germany market size and forecast, by technology
8.3.2.1.2. Germany market size and forecast, by products & services
8.3.2.1.3. Germany market size and forecast, by application
8.3.2.1.4. Germany market size and forecast, by end user

8.3.2.2. France transcriptomics market

8.3.2.2.1. France market size and forecast, by technology
8.3.2.2.2. France market size and forecast, by products & services
8.3.2.2.3. France market size and forecast, by application
8.3.2.2.4. France market size and forecast, by end user

8.3.2.3. UK transcriptomics market

8.3.2.3.1. UK market size and forecast, by technology
8.3.2.3.2. UK market size and forecast, by products & services
8.3.2.3.3. UK market size and forecast, by application
8.3.2.3.4. UK market size and forecast, by end user

8.3.2.4. Italy transcriptomics market

8.3.2.4.1. Italy market size and forecast, by technology
8.3.2.4.2. Italy market size and forecast, by products & services
8.3.2.4.3. Italy market size and forecast, by application
8.3.2.4.4. Italy market size and forecast, by end user

8.3.2.5. Spain transcriptomics market

8.3.2.5.1. Spain market size and forecast, by technology
8.3.2.5.2. Spain market size and forecast, by products & services
8.3.2.5.3. Spain market size and forecast, by application
8.3.2.5.4. Spain market size and forecast, by end user

8.3.2.6. Rest of Europe transcriptomics market

8.3.2.6.1. Rest of Europe market size and forecast, by technology
8.3.2.6.2. Rest of Europe market size and forecast, by products & services
8.3.2.6.3. Rest of Europe market size and forecast, by application
8.3.2.6.4. Rest of Europe market size and forecast, by end user

8.3.3. Europe market size and forecast, by technology
8.3.4. Europe market size and forecast, by products & services
8.3.5. Europe market size and forecast, by application
8.3.6. Europe market size and forecast, by end user

8.4. ASIA-PACIFIC

8.4.1. Key market trends, growth factors and opportunities
8.4.2. Asia-Pacific market size and forecast, by country

8.4.2.1. Japan transcriptomics market

8.4.2.1.1. Japan market size and forecast, by technology
8.4.2.1.2. Japan market size and forecast, by products & services
8.4.2.1.3. Japan market size and forecast, by application
8.4.2.1.4. Japan market size and forecast, by end user

8.4.2.2. China transcriptomics market

8.4.2.2.1. China market size and forecast, by technology
8.4.2.2.2. China market size and forecast, by products & services
8.4.2.2.3. China market size and forecast, by application
8.4.2.2.4. China market size and forecast, by end user

8.4.2.3. India transcriptomics market

8.4.2.3.1. India market size and forecast, by technology
8.4.2.3.2. India market size and forecast, by products & services
8.4.2.3.3. India market size and forecast, by application
8.4.2.3.4. India market size and forecast, by end user

8.4.2.4. Australia transcriptomics market

8.4.2.4.1. Australia market size and forecast, by technology
8.4.2.4.2. Australia market size and forecast, by products & services
8.4.2.4.3. Australia market size and forecast, by application
8.4.2.4.4. Australia market size and forecast, by end user

8.4.2.5. Rest of Asia-Pacific transcriptomics market

8.4.2.5.1. Rest of Asia-Pacific market size and forecast, by technology
8.4.2.5.2. Rest of Asia-Pacific market size and forecast, by products & services
8.4.2.5.3. Rest of Asia-Pacific market size and forecast, by application
8.4.2.5.4. Rest of Asia-Pacific market size and forecast, by end user

8.4.3. Asia-Pacific market size and forecast, by technology
8.4.4. Asia-Pacific market size and forecast, by products & services
8.4.5. Asia-Pacific market size and forecast, by application
8.4.6. Asia-Pacific market size and forecast, by end user

8.5. LAMEA

8.5.1. Key market trends, growth factors and opportunities
8.5.2. LAMEA market size and forecast, by country

8.5.2.1. Brazil transcriptomics market

8.5.2.1.1. Brazil market size and forecast, by technology
8.5.2.1.2. Brazil market size and forecast, by products & services
8.5.2.1.3. Brazil market size and forecast, by application
8.5.2.1.4. Brazil market size and forecast, by end user

8.5.2.2. South Africa transcriptomics market

8.5.2.2.1. South Africa market size and forecast, by technology
8.5.2.2.2. South Africa market size and forecast, by products & services
8.5.2.2.3. South Africa market size and forecast, by application
8.5.2.2.4. South Africa market size and forecast, by end user

8.5.2.3. Saudi Arabia transcriptomics market

8.5.2.3.1. Saudi Arabia market size and forecast, by technology
8.5.2.3.2. Saudi Arabia market size and forecast, by products & services
8.5.2.3.3. Saudi Arabia market size and forecast, by application
8.5.2.3.4. Saudi Arabia market size and forecast, by end user

8.5.2.4. Rest of LAMEA transcriptomics market

8.5.2.4.1. Rest of LAMEA market size and forecast, by technology
8.5.2.4.2. Rest of LAMEA market size and forecast, by products & services
8.5.2.4.3. Rest of LAMEA market size and forecast, by application
8.5.2.4.4. Rest of LAMEA market size and forecast, by end user

8.5.3. LAMEA market size and forecast, by technology
8.5.4. LAMEA market size and forecast, by products & services
8.5.5. LAMEA market size and forecast, by application
8.5.6. LAMEA market size and forecast, by end user

CHAPTER 9 COMPANY PROFILES

9.1. AGILENT TECHNOLOGIES INC.

9.1.1. Company overview
9.1.2. Company snapshot
9.1.3. Operating business segments
9.1.4. Product portfolio
9.1.5. Business performance

9.2. BIO-RAD LABORATORIES, INC.

9.2.1. Company overview
9.2.2. Company snapshot
9.2.3. Operating business segments
9.2.4. Product portfolio
9.2.5. Business performance

9.3. GENERAL ELECTRIC COMPANY

9.3.1. Company overview
9.3.2. Company snapshot
9.3.3. Operating business segments
9.3.4. Product portfolio
9.3.5. Business performance

9.4. F. HOFFMANN-LA ROCHE LTD.

9.4.1. Company overview
9.4.2. Company snapshot
9.4.3. Operating product categories
9.4.4. Product portfolio
9.4.5. Business performance

9.5. FLUIDIGM CORPORATION

9.5.1. Company overview
9.5.2. Company snapshot
9.5.3. Operating business segments
9.5.4. Product portfolio
9.5.5. Business performance

9.6. ILLUMINA, INC.

9.6.1. Company overview
9.6.2. Company snapshot
9.6.3. Operating business segments
9.6.4. Product portfolio
9.6.5. Business performance

9.7. MERCK & CO., INC.

9.7.1. Company overview
9.7.2. Company snapshot
9.7.3. Operating business segments
9.7.4. Merck: Product portfolio
9.7.5. Business performance

9.8. PROMEGA CORPORATION

9.8.1. Company overview
9.8.2. Company snapshot
9.8.3. Operating business segments
9.8.4. Product portfolio
9.8.5. Key strategic moves and developments

9.9. QIAGEN N.V.

9.9.1. Company overview
9.9.2. Company snapshot
9.9.3. Operating business segments
9.9.4. Product portfolio
9.9.5. Business performance
9.9.6. Key strategic moves and developments

9.10. THERMO FISHER SCIENTIFIC INC

9.10.1. Company overview
9.10.2. Company snapshot
9.10.3. Operating business segments
9.10.4. Product portfolio
9.10.5. Business performance